Physician profile
Jonathan A Holt
NPI 1487061149
$1,321.10
in general payments reported to CMS, 2019-2025
13 companies · $125 in 2025
The $125 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $56.87 · 2021: $301 · 2022: $83.89 · 2023: $199 · 2024: $217 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $423.74 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Janssen Pharmaceuticals, INC | $153.49 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $142.53 | 2023 | Dysport |
| Astrazeneca Pharmaceuticals LP | $135.72 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $122.38 | 2019-2024 | Zerbaxa, Recarbrio, Dificid |
| Philips North America LLC | $86.44 | 2019 | |
| Pfizer INC. | $67.61 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $55.95 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.98 | 2024 | Lifevest |
| Allergan, INC. | $29.23 | 2019 | |
| Scpharmaceuticals INC. | $24.09 | 2024 | |
| Bioventus LLC | $23.44 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.